Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.0022 | 0.9 |
mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0021 | 0.9 |
mRNA | Roscovitine | FIMM | pan-cancer | AAC | -0.011 | 1 |
mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.0031 | 1 |
mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.0031 | 1 |
mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | -0.002 | 1 |
mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | -0.004 | 1 |
mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.0017 | 1 |